New York Post highlights cutting-edge hair care and treatment innovation in South Korea

Source: New York Post (external media)

A recent feature published by the New York Post explores how South Korea is emerging as a leading hub for advanced hair and scalp-care innovation. The article highlights growing public and professional interest in new approaches addressing hereditary and age-related hair thinning.

According to the report, South Korea’s strong biotechnology, medical aesthetics and cosmetic research ecosystem is accelerating the development of novel solutions, including non-invasive technologies and next-generation topical and procedural approaches. The coverage reflects a broader industry trend toward more targeted and technology-driven hair and scalp care.

The article also notes that public awareness and policy-level discussions surrounding hair health have increased in recent years, reinforcing the visibility of this sector within Korea’s healthcare and beauty landscape.

This external coverage illustrates the growing global focus on innovation originating from South Korea in the field of hair and scalp care. The summary below is provided solely as an editorial overview of third-party reporting.

External media reference

New York Post (2 February 2026)
The cutting-edge hair growth treatments of South Korea — where the president has called balding a “matter of survival”
View original article

This journal entry references an article published by a third-party media outlet. The summary above is an independent editorial overview and is provided for informational purposes only. It is not intended to diagnose, treat, cure, or prevent any medical condition.

Latest Stories

View all

New York Post highlights cutting-edge hair care and treatment innovation in South Korea

New York Post highlights cutting-edge hair care and treatment innovation in South Korea

New York Post highlights cutting-edge hair care and treatment innovation in South Korea Source: New York Post (external media) A recent feature published by the New York Post explores how South Korea is emerging as a leading hub for advanced...

Read moreabout New York Post highlights cutting-edge hair care and treatment innovation in South Korea

Clinical Trial Evidence (RCT): CosmeRNA ARI in European Androgenetic Alopecia

Clinical Trial Evidence (RCT): CosmeRNA ARI in European Androgenetic Alopecia

A 2025 clinical research article published in Clinical and Experimental Dermatology and Therapies reports the results of a six-month, double-blind, randomized, placebo-controlled trial evaluating CosmeRNA ARI in adults with androgenetic alopecia in Germany.

Read moreabout Clinical Trial Evidence (RCT): CosmeRNA ARI in European Androgenetic Alopecia

EADV Congress 2025 – Hair and Nail Disorders Abstract Book

EADV Congress 2025 – Hair and Nail Disorders Abstract Book

A clinical research abstract presented at the EADV Congress 2025 reported findings from a randomised, double-blind, placebo-controlled study investigating an androgen-receptor-regulating topical approach in women with female pattern hair loss.

Read moreabout EADV Congress 2025 – Hair and Nail Disorders Abstract Book